Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Talbot JN, Montravers F, Kerrou K, Nataf V, Chevalme Y. FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines. Eur J Nucl Med Mol Imaging 2007; in press. DOI 10.​1007/​s00259-007-0400-y.
2.
Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, et al. EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging 2006;33:1374–80.CrossRef
3.
Chen W, Delaloye S, Czernin J, Silverman DH, Pope W, Satyamurthy N, et al. Predicting response of malignant brain tumors to bevacizumab and irinotecan therapy with FLT and FDOPA PET. SNM annual meeting 2006, N° 221.
4.
Chen W, Delaloye S, Cloughesy T, Mischel P, Bergsneider M, Satyamurthy N, et al. FDOPA uptake kinetics in human gliomas and the relationship to histopathologic tumor cell proliferation index Ki-67. SNM annual meeting 2006, N° 222.
5.
Heiss WD, Wienhard K, Wagner R, Lanfermann H, Thiel A, Herholz K, et al. F-dopa as an amino acid tracer to detect brain tumors. J Nucl Med 1996;37:1180–2.PubMed
6.
Becherer A, Karanikas G, Szabo M, Zettinig G, Asenbaum S, Marosi C, et al. Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine. Eur J Nucl Med Mol Imaging 2003;30:1561–7.PubMedCrossRef
7.
Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 2006;47:904–11.PubMed
Metadata
Title
Reply
Authors
T. Vander Borght
S. Asenbaum
P. Bartenstein
C. Halldin
Ö. Kapucu
K. Van Laere
A. Varrone
K. Tatsch
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0408-3

Other articles of this Issue 7/2007

European Journal of Nuclear Medicine and Molecular Imaging 7/2007 Go to the issue

Letter to the Editor

Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

Original article

Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement

Original Article

Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: a study based on the J-ACCESS database

Original article

Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography

Original Article

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Original Article

123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients